Japan to lead human trial using stem cell to treat Parkinson's

A team of researchers from Kyoto University, Japan has announced the world's first human trial using a kind of stem cell...

July 31, 2018 | Tuesday | News
SanBio Receives $20 Million Grant From CIRM

SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...

July 30, 2018 | Monday | News
Mylan, Fujifilm Kyowa Kirin Biologics declares positive CHMP opinion for Hulio

Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the European Medicines Agency's Committee for Med...

July 30, 2018 | Monday | News
Solasia Pharma announces approval of Sancusco in China

Japan's Solasia Pharma, a specialty pharmaceutical company based in Asia, has officially announced that Sancuso (Granise...

July 27, 2018 | Friday | News
Eisai, Biogen present Clinical study of Elenbecestat for Alzheimer's at AAIC 2018

Eisai Co., Ltd. and Biogen Inc. announced detailed results from a Phase II clinical study (Study 202) of the investigati...

July 26, 2018 | Thursday | News
Terumo acquires China based Essen Tech

Terumo Corporation recently announced that it has entered into an agreement to acquire Essen Technology (Beijing) Co., L...

July 26, 2018 | Thursday | News
Oramed gets Japanese Patent for GLP-1 analog capsule

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via...

July 24, 2018 | Tuesday | News
Researchers use AI to diagnose stomach cancer

Researchers at Riken and the National Cancer Centre in Japan have succeeded in using artificial intelligence (AI) to ide...

July 24, 2018 | Tuesday | News
Eisai to bring NAILIN capsules in japan

Sato Pharmaceutical obtained marketing and manufacturing approval for NAILIN® Capsules 100mg as an oral treatment fo...

July 19, 2018 | Thursday | News
Latest Data on Eisai's Alzheimer's disease to be presented at AAIC 2018

Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...

July 19, 2018 | Thursday | News
Japan's Otsuka Pharma to acquire Visterra for $430 mn

Japan's Otsuka Pharmaceutical recently announced that it has acquired  US-based Visterra  for approximately US...

July 18, 2018 | Wednesday | News
Ieon-nanodrugs announces collaboration with Takeda

leon-nanodrugs GmbH is pleased to announce that its proprietary MicroJet Reactor nano-technology has been selected ...

July 17, 2018 | Tuesday | News
Otsuka acquires Visterra for $430 M

Otsuka Pharmaceutical Co., Ltd. and Visterra, Inc. have announced that they have entered into a definitive merger a...

July 13, 2018 | Friday | News
Takeda bags Japan's approval for ulcerative colitis drug

Japan's Takeda Pharmaceutical Company recently announced that it has obtained a New Drug Application Approval from the J...

July 6, 2018 | Friday | News
Researchers in Japan devise method to produce steroid antibiotics

A group of researchers at the University of Tokyo, Japan, has developed a method to produce steroid antibiotics that do ...

July 5, 2018 | Thursday | News
Philips powers first tele-intensive care eICU program in Japan

Royal Philips, a global leader in health technology, and Japan-based Showa University announced the launch of Japan's fi...

July 4, 2018 | Wednesday | News
PharmaMar, Chugai terminate License Agreement for Zepsyre

Chugai Pharmaceutical Co., Ltd. had exercised its right to terminate without cause the License, Development and Commerci...

June 27, 2018 | Wednesday | News
Lupin, Nichi-Iko unite to market biosimilar Etanercept in Japan

Pharma major Lupin and Nichi-Iko announced that the two companies have entered into an agreement for the distribution, p...

June 18, 2018 | Monday | News